Biotech startups may be eligible for research and development tax credits more frequently than they think. A report by K-38 Consulting highlights this possibility.

The report suggests that many biotech startups qualify for these credits, but may not be aware of their eligibility. Further details on the report's findings are available from K-38 Consulting.

For biotech startups looking to learn more about potential tax credits, the report provides information on qualification and eligibility.